Natural Killer (NK) cells are innate immune cells that can directly detect and kill cancer cells. Understanding the molecular determinants regulating human NK cell cytotoxicity could help harness these cells for cancer therapies. To this end, we compared the transcriptome of NK cell clones derived from human peripheral blood, which were strongly or weakly cytotoxic against 721.221 and other target cells. After one month of culture, potent NK cell clones showed a significant upregulation in genes involved in cell cycle progression, suggesting that proliferating NK cells were particularly cytotoxic. Beyond two months of culture, NK cell clones which were strongly cytotoxic varied in their expression of 28 genes, including and ; NK cells with high levels of expression were weakly cytotoxic while high correlated with strong cytotoxicity. Thus, NK cells were cultured and sorted for expression of CD70 and CD8α, and in accordance with the transcriptomic data, CD70 NK cells showed low cytotoxicity against 721.221 and K562 target cells. Cytotoxicity of CD70 NK cells could be enhanced using blocking antibodies against CD70, indicating a direct role for CD70 in mediating low cytotoxicity. Furthermore, time-lapse microscopy of NK cell-target cell interactions revealed that CD8α NK cells have an increased propensity to sequentially engage and kill multiple target cells. Thus, these two markers relate to NK cell populations which are capable of potent killing (CD70) or serial killing (CD8α).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11880019PMC
http://dx.doi.org/10.3389/fimmu.2025.1526379DOI Listing

Publication Analysis

Top Keywords

cells
13
cell clones
12
target cells
12
natural killer
8
cell
8
cell populations
8
weakly cytotoxic
8
cd70 cells
8
low cytotoxicity
8
cytotoxicity
6

Similar Publications

Historical studies performed nearly a century ago using mouse skin models identified two key steps in cancer evolution: initiation, a likely mutational event, and promotion, driven by inflammation and cell proliferation. Initiation was proposed to be permanent, with promotion as the critical rate-limiting step for cancer development. Here, we carried out whole genome sequencing to demonstrate that initiated cells with thousands of mutagen-induced mutations can persist for long periods and are not removed by cell competition or by immune intervention, thus mimicking the persistence of cells with cancer driver mutations in normal human tissues.

View Article and Find Full Text PDF

It is known that inhibition of the endoplasmic reticulum transmembrane signaling protein (ERN1) suppresses the glioblastoma cells proliferation. The present study aims to investigate the impact of inhibition of ERN1 endoribonuclease and protein kinase activities on the , , and gene expression in U87MG glioblastoma cells with an intent to reveal the role of ERN1 signaling in the regulation of expression of these genes. The U87MG glioblastoma cells with inhibited ERN1 endoribonuclease (dnrERN1) or both enzymatic activities of ERN1 (endoribonuclease and protein kinase; dnERN1) were used.

View Article and Find Full Text PDF

For the effective growth of malignant tumors, including glioblastoma, the necessary factors involve endoplasmic reticulum (ER) stress, hypoxia, and the availability of nutrients, particularly glucose. The ER degradation enhancing alpha-mannosidase like protein 1 (EDEM1) is involved in ER-associated degradation (ERAD) targeting misfolded glycoproteins for degradation in an N-glycan-independent manner. EDEM1 was also identified as a new modulator of insulin synthesis and secretion.

View Article and Find Full Text PDF

We report the cosolvency effect of formamidinium lead triiodide (FAPbI) in a mixture of γ-butyrolactone (GBL) and 2-methoxyethanol (2ME), a phenomenon where FAPbI shows higher solubility in the solvent blend than in either alone. We found that FAPbI exhibits 10× higher solubility in 30% 2ME in GBL than in 2ME alone and 40% higher solubility than in GBL alone at 90 °C. This enhanced solubility is attributed to the disruption of the hydrogen bonding network within 2ME, allowing its hydroxyl and ether groups to interact more freely with the solute.

View Article and Find Full Text PDF

Background: Congenital cytomegalovirus is the leading cause of nongenetic sensorineural hearing loss. Treatment with (val)ganciclovir improves audiologic outcomes. Neutropenia is a common adverse event, but correlates that predict who will develop neutropenia have not been identified.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!